Stabilization of human urine doping control samples: II. Microbial degradation of steroids

Analytical Biochemistry

Volumn 388, Issue 1, 2009, Pages 146-154

  Tsivou, M ^a,b   Livadara, D ^a,b   Georgakopoulos, D G ^c   Koupparis, M A ^b   Atta Politou, J ^b   Georgakopoulos, C G ^a  

^a Olympic Athletic Center of Athens   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Doping control analysis; Endogenous steroids; Mass spectrometry; Microorganisms; Stabilization; Urine

Indexed keywords

DEGRADATION; GAS CHROMATOGRAPHY; LIPIDS; MASS SPECTROMETRY; MICROORGANISMS; MIXTURES; ORGANIC POLYMERS; STABILIZATION; SULFUR COMPOUNDS;

ACCREDITED LABORATORIES; CHEMICAL STABILIZATION; DOPING CONTROL ANALYSIS; ENDOGENOUS STEROIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRIES (GC-MS); TRANSPORTATION PERIOD; URINE; WORLD ANTI-DOPING AGENCY;

BIODEGRADATION;

19 NORSTEROID; ANDROSTENEDIONE; ANDROSTERONE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BOLDENONE; EPITESTOSTERONE; ETIOCHOLANOLONE; GLUCURONIDE; PRASTERONE SULFATE; PROTEINASE INHIBITOR; STEROID; SULFATE;

ARTICLE; CONTROLLED STUDY; DOPING; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; INCUBATION TIME; INOCULATION; MASS FRAGMENTOGRAPHY; MICROBIAL ACTIVITY; MICROBIAL DEGRADATION; MICROBIAL GROWTH; NONHUMAN; PH; PRESERVATION; PRIORITY JOURNAL; RELATIVE DENSITY; URINE;

EID: 63149142542     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.02.013     Document Type: Article

References (40)

1. Lauer B.A., Reller L.B., and Mirrett S. Evaluation of preservative fluid for urine collected for culture. J. Clin. Microbiol. 10 (1979) 42-45
2. Honour J.W. Testing for drug abuse. Lancet 348 (1996) 41-43
3. Hemmersbach P., Birkeland K.I., Norli H.R., and Ringertz S.H. Urine storage conditions and steroid profile analysis. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent Advances in Doping Analysis vol. 4 (1997), Sport & Buch Strauß, Köln, Germany 99-106
4. Gillespie Τ., Fewster J., and Masterton R.G. The effect of specimen processing delay on borate urine preservation. J. Clin. Pathol. 52 (1999) 95-98
5. Molaioni F., Abate M.G., Alocci R., Mazzarino M., Rossi F., and Botre F. Urine stability, steroid profile, and T/E ratio: Towards an index of sample degradation. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 13 (2005), Sport & Buch Strauß, Köln, Germany 179-188
6. Mareck U., Geyer H., Opfermann G., Thevis M., and Schänzer W. Factors influencing the steroid profile in doping control analysis. J. Mass Spectrom. 43 (2008) 877-891
7. Geyer H., Schänzer W., Mareck-Engelke U., and Donike M. Factors influencing the steroid profile. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent Advances in Doping Analysis vol. 3 (1995), Sport & Buch Strauß, Köln, Germany 95-113
8. Ayotte C., Goudreault D., and Charlebois A. Testing for natural and synthetic anabolic agents in human urine. J. Chromatogr. B 687 (1996) 3-25
9. Ayotte C., Charlebois A., Lapointe S., Barriault D., and Sylvestre M. Validity of urine samples: Microbial degradation. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent Advances in Doping Analysis vol. 4 (1997), Sport & Buch Strauß, Köln, Germany 127-137
10. van de Kerkhof D.H., de Boer D., Thijssen J.H.H., and Maes R.A.A. Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis. J. Anal. Toxicol. 24 (2000) 102-115
11. de la Torre R., de la Torre X., Alia C., Segura J., Baro T., and Torres-Rodriguez J.M. Changes in androgenic steroid profile due to urine contamination by microorganisms: A prospective study. Anal. Biochem. 289 (2001) 116-122
12. Bilton R.F. Microbial production of testosterone. Lancet 345 (1995) 1186-1187
13. Kicman A.T., Fallon J.K., Cowan D.A., Walker C., Easmon S., and Mackintosh D. Candida albicans in urine can produce testosterone: Impact on the testosterone/epitestosterone sports drug test. Clin. Chem. 48 (2002) 1799-1801
14. Schänzer W., and Donike M. Metabolism of boldenone in man: Gas chromatographic/mass spectrometric identification of urinary excreted metabolites and determination of excretion rates. Biol. Mass Spectrom. 21 (1992) 3-16
15. van der Kerkhof D.H., van der Voort P.M., de Boer D., and Maes R.A.A. Confirmation of endogenous boldenone production: A procedure for an in vivo experiment. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent Advances in Doping Analysis vol. 17 (1999), Sport & Buch Strauß, Köln, Germany 161-168
16. Rautenberg C., Grosse J., Thieme D., Wassill L., Ganghofner D., and Mueller R.K. Testosterone degradation induced by Rh. erythropolis. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 14 (2006), Sport & Buch Strauß, Köln, Germany 379-382
17. Grosse J., Rautenberg C., Wassill L., Ganghofner D., and Thieme D. Degradation of doping-relevant steroids by Rh. Erythropolis. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 15 (2007), Sport & Buch Strauß, Köln, Germany 385-388
18. VPDB values of trace amounts of boldenone and its main metabolite. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 15 (2007), Sport & Buch Strauß, Köln, Germany 169-178
19. Thieme D., Anielski P., Grosse J., Hemmersbach P., Lund H., and Rautenberg C. Kinetic of in-situ demethylation of deuterated endogenous steroids in urine samples. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 12 (2004), Sport & Buch Strauß, Köln, Germany 177-188
20. Grosse J., Anielski P., Hemmersbach P., Lund H., Mueller R.K., Rautenberg C., and Thieme D. Formation of 19-norsteroids by in situ demethylation of endogenous steroids in stored urine samples. Steroids 70 (2005) 499-506
21. Rautenberg C., Grosse J., Anielski P., Thieme D., Hemmersbach P., Lund H.S., and Mueller R.K. Aspects of in situ formation of 190-norsteroids. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 13 (2005), Sport & Buch Strauß, Köln, Germany 449-452
22. M. Tsivou, D. Livadara, D.G. Georgakopoulos, M. Koupparis, J. Atta-Politou, C.G. Georgakopoulos, Preservation of urine doping control samples: Preliminary results, in: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (Eds.), Recent Advances in Doping Analysis, vol. 16, Sport & Buch Strauß, Köln, Germany, 2008, pp. 41-50.
23. Lamon S., Robinson N., Sottas P.-E., Henry H., Kamber M., Mangin P., and Saugy M. Possible origin of undetectable EPO in urine samples. Clin. Chim. Acta 385 (2007) 61-66
24. Thevis Μ., Maurer J., Kohler M., and Schänzer W. Proteases in doping control analysis. Intl. J. Sports Med. 28 (2007) 545-549
25. Dehnes Y., Borgen M., and Hemmersbach P. Enzymatic digestion of EPO. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 15 (2007), Sport & Buch Strauß, Köln, Germany 405-408
26. Maurer J., Kohler M., Schänzer W., and Thevis M. Identification of proteolytic enzymes in human urine. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 15 (2007), Sport & Buch Strauß, Köln, Germany 283-291
27. Iravani A. Advances in the understanding and treatment of urinary tract infections in young women. Urology 37 (1991) 503-511
28. Wilkie M.E., Almond M.K., and Marsh F.P. Diagnosis and management of urinary tract infection in adults. Br. Med. J. 305 (1992) 1137-1141
29. McCarty J.M., Richard G., Huck W., Tucker R.M., Tosiello R.L., Shan M., Heyd A., and Echols R.M. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am. J. Med. 106 (1999) 292-299
30. Wilson M.L., and Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin. Infect. Dis. 38 (2004) 1150-1158
31. Johnson J.R., and Stamm W.E. Urinary tract infections in women: Diagnosis and treatment. Ann. Intern. Med. 111 (1989) 906-917
32. Kaufmann G., Thole H., Kraft R., and Atrat P. Steroid-1-dehydrogenase of Rhodococcus erythropolis. J. Steroid Biochem. Mol. Biol. 43 (1992) 297-301
33. Nixon A., Mallet A.I., H Jackman P.J., and Gower D.B. Testosterone metabolism by isolated human axillary Corynebacterium spp.: A gas chromatographic mass-spectrometric study. J. Steroid Biochem. 24 (1986) 887-892
34. Lasne F., Martin L., and de Ceaurriz J. Active urine and detection of recombinant erythropoietin. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 13 (2005), Sport & Buch Strauß, Köln, Germany 297-304
35. Kwiatkowska D., Pokrywka A., Jaźwiec R., Turek-Lepa E., Starościak B., Lewandowska-Pachecka S., Pachecka J., and Grucza R. The research of microbiological stability in anti-doping samples. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis vol. 13 (2005), Sport & Buch Strauß, Köln, Germany 453-456
36. Kastelic-Suhadolc T., Plemenitas A., and Zigon D. Isolation and identification of testosterone and androstenedione in the fungus Cochliobolus lunatus. Steroids 59 (1994) 357-361
37. Rizner T.L., Adamski J., and Zakelj-Mavric M. Expression of 17β-hydroxysteroid dehydrogenases in mesophilic and extremophilic yeast. Steroids 66 (2001) 49-54
38. Muñoz P., Gijón P., Alcalà L., and Bouza E. How to manage candiduria. Rev. Med. Microbiol. 9 (1998) 225-231
39. World Anti-Doping Agency, Reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio, and other endogenous steroids [WADA technical document no. TD2004EAAS], http://www.wada-ama.org/rtecontent/document/end_steroids_aug_04.pdf.
40. Groh H., Schade K., and Hörhold-Schube C. Steroid metabolism with intestinal microorganisms. J. Basic Microbiol. 33 (1993) 59-72